Exploring Chinese Herbal Medicine Can Foster Discovery Of Better Drugs

Of Better Drugs Author: Tianhan Xue The scientific merits of traditional and herbal remedies have been a topic of great controversy. Critics, including many scientists, have questioned whether claimed effects of such alternative therapies can stand up to rigorous tests that apply to conventional medicine, and even whether they are science at all. Yet, as is evidenced by an examination of Chinese herbal medicine (CHM), the therapeutic effects of some herbal remedies have been scientifically pr

Written byTianhan Xue
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Of Better Drugs Author: Tianhan Xue
The scientific merits of traditional and herbal remedies have been a topic of great controversy. Critics, including many scientists, have questioned whether claimed effects of such alternative therapies can stand up to rigorous tests that apply to conventional medicine, and even whether they are science at all. Yet, as is evidenced by an examination of Chinese herbal medicine (CHM), the therapeutic effects of some herbal remedies have been scientifically proven, and they represent a significant source of new pharmaceuticals. However, regulatory hurdles, along with other factors, have impeded the development of herb-derived drugs in the United States. It is time now to take measures that encourage scientific research on herbal remedies as an alternative approach to the discovery of new and better therapies.

CHM is an organized system of medical knowledge, passed down from one generation to another in both written and unwritten form, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies